Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Current adolescent alcohol treatments have modest effects and high relapse rates. Evaluation of novel pharmacotherapy treatments is warranted. N-acetylcysteine (NAC), an over-the-counter antioxidant supplement with glutamatergic properties, is a promising treatment for marijuana cessation in adolescents; however, its effects on adolescent drinking have not been examined. To that end, this secondary analysis evaluated: (1) the effect of NAC vs. placebo on alcohol use over an 8-week adolescent marijuana cessation trial and (2) the role of marijuana cessation and reduction on subsequent alcohol use. Marijuana-dependent adolescents (ages 15–21; N=116) interested in treatment were randomized to NAC 1200mg or matched placebo twice daily for 8 weeks. Participants were not required to be alcohol users or interested in alcohol cessation to qualify. There were no demographic or baseline alcohol use differences between participants randomized to NAC vs. placebo (ps>.05). Of the 89 participants returning for ≥1 visit following randomization, 77 reported ≥1 alcoholic drink in the 30 days prior to study entry and averaged 1.3 (SD=1.4) binge drinking days per week. During treatment, less marijuana use (measured via urine cannabinoid levels) was associated with less alcohol use in the NAC-treated group but not in the placebo-treated group (p=0.016). There was no evidence of compensatory alcohol use during marijuana treatment. In fact, in the NAC group, lower levels of marijuana use were associated with less alcohol use, suggesting NAC effects may generalize to other substances and could be useful in decreasing adolescent alcohol use. NAC trials specifically focused on alcohol-using adolescents are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zero-Inflated Poisson Regression, with an Application to Defects in Manufacturing
Lambert, D. (1992) · Technometrics · doi:10.2307/1269547 · Cited by 3,988 · cited 1×
“The parameter estimates from the Poisson/Negative Binomial portion of the model assessed the increased or decreased effects of the independent variables on number of drinks, drinking days, and binge drinking days within the at-risk group (He, Tang, Wang, & Crits-Christoph, 2014; Lambert, 1992).”
Sheehan, D. V., Sheehan, K. H., Shytle, R. D., Janavs, J., Bannon, Y., Rogers, J. E., Milo, K. M., Stock, S. L., & Wilkinson, B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05305whi · Cited by 1,730
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523 · cited 2×
“Several adverse outcomes are associated with adolescent alcohol and marijuana use, including poorer psychosocial (Miller, Naimi, Brewer, & Jones, 2007), cognitive (Jacobus et al., 2015; Meier et al., 2012; Nguyen-Louie et al., 2015; Squeglia & Gray, 2016; Squeglia, Spadoni, Infante, Myers, & Tapert, 2009), and educati…”
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 1×
“Based on preclinical findings, glutamate has emerged as a potential pharmacotherapeutic target in the treatment of addictions (Kalivas, 2009; Kalivas & Volkow, 2011).”
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Binge drinking and associated health risk behaviors among high school students
Miller, J. W., Naimi, T. S., Brewer, R. D., & Jones, S. E. (2007) · Pediatrics · doi:10.1542/peds.2006-1517 · Cited by 888
A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
Self-citationSqueglia, L. M., Spadoni, A. D., Infante, M. A., Myers, M. G., & Tapert, S. F. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0016516 · Cited by 225
Self-citationN‐Acetylcysteine (NAC) in Young Marijuana Users: An Open‐Label Pilot Study
Gray, K. M., Watson, N. L., Carpenter, M. J., & LaRowe, S. D. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00027.x · Cited by 109
Self-citationLatvala, A., Rose, R. J., Pulkkinen, L., Dick, D. M., Korhonen, T., & Kaprio, J. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.01.016 · Cited by 102
Cited by
Raghu, G., Berk, M., Campochiaro, P. A., Jaeschke, H., Marenzi, G., Richeldi, L., Wen, F.-Q., Nicoletti, F., & Calverley, P. M. A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666201230144109 · Cited by 280
Pharmacotherapies for cannabis dependence
Nielsen, S., Gowing, L., Sabioni, P., & Le Foll, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008940.pub3 · Cited by 96
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87
Pharmacological Treatment of Youth Substance Use Disorders
Squeglia, L. M., Fadus, M. C., McClure, E. A., Tomko, R. L., & Gray, K. M. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0009 · Cited by 79
Self-citationNamba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
Metadata
- Authors
- Squeglia, L. M., Baker, N. L., McClure, E. A., Tomko, R. L., Adisetiyo, V., & Gray, K. M.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 63
- Pages
- 172-177
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2490647320
- Cited by
- 38
- References
- 10
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.